Simplex Trading
BNTC icon

Simplex Trading’s Benitec Biopharma BNTC Stock Holding History

Simplex Trading’s Portfolio BNTC Stock Details BNTC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-100
Closed -$1.35K – 9084
2025
Q4 		$1.35K Hold
100
– – ﹤0.01% 7957
2025
Q3 		$1K Hold
100
– – ﹤0.01% 8771
2025
Q2 		$1K Buy
+100
New +$1.4K ﹤0.01% 8258
2022
Q3 		– Sell
-465
Closed -$9K – 9916
2022
Q2 		$9K Buy
+465
New +$10.8K ﹤0.01% 8350

Other funds holding BNTC

SCM
Suvretta Capital Management New York $3.92B AUM 86.67% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return
RCM
RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return
NCM
Nantahala Capital Management New Canaan, Connecticut $2.72B AUM 121.58% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
IAM
Infinitum Asset Management Fort Lauderdale, Florida $801M AUM 8.83% 1-Year Est. Return
Alyeska Investment Group
Alyeska Investment Group Chicago, Illinois $35.4B AUM 33.54% 1-Year Est. Return

Simplex Trading's BNTC Position: Q4 2025 in Review

Simplex Trading sold out of Benitec Biopharma (BNTC) in Q4 2025, closing a stake of 72 shares — an estimated $996 sold.

Simplex Trading first reported a position in BNTC in Q1 2022 and held it in 5 quarters. The position peaked at $7K in Q2 2022. 72 funds tracked by Wall St. Rank hold BNTC as of Q4 2025.

  • Simplex Trading reported no remaining Benitec Biopharma position as of Q4 2025 after selling out during the quarter.
  • Simplex Trading sold 72 Benitec Biopharma shares in Q4 2025, an estimated $996.
  • Simplex Trading first reported a position in Benitec Biopharma in Q1 2022 and held it in 5 quarters.
  • Simplex Trading's Benitec Biopharma position peaked at $7K in Q2 2022.
  • 72 funds tracked by Wall St. Rank held Benitec Biopharma as of Q4 2025.

Based on Simplex Trading's 13F filing for Q4 2025, filed 11 Feb 2026.